269 related articles for article (PubMed ID: 23041501)
1. Treatment with pharmacological PPARα agonists stimulates the ubiquitin proteasome pathway and myofibrillar protein breakdown in skeletal muscle of rodents.
Ringseis R; Keller J; Lukas I; Spielmann J; Most E; Couturier A; König B; Hirche F; Stangl GI; Wen G; Eder K
Biochim Biophys Acta; 2013 Jan; 1830(1):2105-17. PubMed ID: 23041501
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms involved in 3',5'-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle.
Gonçalves DA; Lira EC; Baviera AM; Cao P; Zanon NM; Arany Z; Bedard N; Tanksale P; Wing SS; Lecker SH; Kettelhut IC; Navegantes LC
Endocrinology; 2009 Dec; 150(12):5395-404. PubMed ID: 19837877
[TBL] [Abstract][Full Text] [Related]
3. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
4. Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids.
Baehr LM; Furlow JD; Bodine SC
J Physiol; 2011 Oct; 589(Pt 19):4759-76. PubMed ID: 21807613
[TBL] [Abstract][Full Text] [Related]
5. The ubiquitin-proteasome system and skeletal muscle wasting.
Attaix D; Ventadour S; Codran A; Béchet D; Taillandier D; Combaret L
Essays Biochem; 2005; 41():173-86. PubMed ID: 16250905
[TBL] [Abstract][Full Text] [Related]
6. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
Sacheck JM; Ohtsuka A; McLary SC; Goldberg AL
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091
[TBL] [Abstract][Full Text] [Related]
7. Implication of altered ubiquitin-proteasome system and ER stress in the muscle atrophy of diabetic rats.
Reddy SS; Shruthi K; Prabhakar YK; Sailaja G; Reddy GB
Arch Biochem Biophys; 2018 Feb; 639():16-25. PubMed ID: 29277369
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia.
Silva KA; Dong J; Dong Y; Dong Y; Schor N; Tweardy DJ; Zhang L; Mitch WE
J Biol Chem; 2015 Apr; 290(17):11177-87. PubMed ID: 25787076
[TBL] [Abstract][Full Text] [Related]
9. Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expression.
Fareed MU; Evenson AR; Wei W; Menconi M; Poylin V; Petkova V; Pignol B; Hasselgren PO
Am J Physiol Regul Integr Comp Physiol; 2006 Jun; 290(6):R1589-97. PubMed ID: 16455766
[TBL] [Abstract][Full Text] [Related]
10. Experimental hyperthyroidism in rats increases the expression of the ubiquitin ligases atrogin-1 and MuRF1 and stimulates multiple proteolytic pathways in skeletal muscle.
O'Neal P; Alamdari N; Smith I; Poylin V; Menconi M; Hasselgren PO
J Cell Biochem; 2009 Nov; 108(4):963-73. PubMed ID: 19777444
[TBL] [Abstract][Full Text] [Related]
11. Activating cAMP/PKA signaling in skeletal muscle suppresses the ubiquitin-proteasome-dependent proteolysis: implications for sympathetic regulation.
Silveira WA; Gonçalves DA; Graça FA; Andrade-Lopes AL; Bergantin LB; Zanon NM; Godinho RO; Kettelhut IC; Navegantes LC
J Appl Physiol (1985); 2014 Jul; 117(1):11-9. PubMed ID: 24833777
[TBL] [Abstract][Full Text] [Related]
12. Dystrophin involved in the susceptibility of slow muscles to hindlimb unloading via concomitant activation of TGF-β1/Smad3 signaling and ubiquitin-proteasome degradation in mice.
Zhang P; Li W; Liu H; Li J; Wang J; Li Y; Chen X; Yang Z; Fan M
Cell Biochem Biophys; 2014 Nov; 70(2):1057-67. PubMed ID: 24839113
[TBL] [Abstract][Full Text] [Related]
13. An extract of Artemisia dracunculus L. inhibits ubiquitin-proteasome activity and preserves skeletal muscle mass in a murine model of diabetes.
Kirk-Ballard H; Wang ZQ; Acharya P; Zhang XH; Yu Y; Kilroy G; Ribnicky D; Cefalu WT; Floyd ZE
PLoS One; 2013; 8(2):e57112. PubMed ID: 23437325
[TBL] [Abstract][Full Text] [Related]
14. Absence of caspase-3 protects against denervation-induced skeletal muscle atrophy.
Plant PJ; Bain JR; Correa JE; Woo M; Batt J
J Appl Physiol (1985); 2009 Jul; 107(1):224-34. PubMed ID: 19390003
[TBL] [Abstract][Full Text] [Related]
15. A critical discussion on the relationship between E3 ubiquitin ligases, protein degradation, and skeletal muscle wasting: it's not that simple.
Hughes DC; Goodman CA; Baehr LM; Gregorevic P; Bodine SC
Am J Physiol Cell Physiol; 2023 Dec; 325(6):C1567-C1582. PubMed ID: 37955121
[TBL] [Abstract][Full Text] [Related]
16. Out of Control: The Role of the Ubiquitin Proteasome System in Skeletal Muscle during Inflammation.
Haberecht-Müller S; Krüger E; Fielitz J
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572540
[TBL] [Abstract][Full Text] [Related]
17. Excessive glucocorticoid-induced muscle MuRF1 overexpression is independent of Akt/FoXO1 pathway.
Wang XJ; Xiao JJ; Liu L; Jiao HC; Lin H
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29046370
[TBL] [Abstract][Full Text] [Related]
18. Clenbuterol suppresses proteasomal and lysosomal proteolysis and atrophy-related genes in denervated rat soleus muscles independently of Akt.
Gonçalves DA; Silveira WA; Lira EC; Graça FA; Paula-Gomes S; Zanon NM; Kettelhut IC; Navegantes LC
Am J Physiol Endocrinol Metab; 2012 Jan; 302(1):E123-33. PubMed ID: 21952035
[TBL] [Abstract][Full Text] [Related]
19. Role of ubiquitin-proteasome proteolysis in muscle fiber destruction in experimental chloroquine-induced myopathy.
Kimura N; Kumamoto T; Oniki T; Nomura M; Nakamura K; Abe Y; Hazama Y; Ueyama H
Muscle Nerve; 2009 Apr; 39(4):521-8. PubMed ID: 19296457
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase-4 inhibition reduces proteolysis and atrogenes expression in rat skeletal muscles.
Lira EC; Gonçalves DA; Parreiras-E-Silva LT; Zanon NM; Kettelhut IC; Navegantes LC
Muscle Nerve; 2011 Sep; 44(3):371-81. PubMed ID: 21996797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
